Celina Griffin is a seasoned professional in pharmacovigilance science, currently serving as Senior Director at Merus N.V. Since 2025, they have held various leadership roles in pharmacovigilance, including positions at ImmunoGen and Takeda Oncology. Celina's extensive experience includes serving as Director of Drug Safety & Pharmacovigilance at EQRx and as Clinical Scientist at Wyeth, where they managed clinical trials and developed study protocols. They earned a Doctor of Pharmacy from the Massachusetts College of Pharmacy and Health Sciences and hold a Certificate in Clinical Research from Boston University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices